DK1025846T3 - Vandige flydende præparater - Google Patents
Vandige flydende præparaterInfo
- Publication number
- DK1025846T3 DK1025846T3 DK99938550T DK99938550T DK1025846T3 DK 1025846 T3 DK1025846 T3 DK 1025846T3 DK 99938550 T DK99938550 T DK 99938550T DK 99938550 T DK99938550 T DK 99938550T DK 1025846 T3 DK1025846 T3 DK 1025846T3
- Authority
- DK
- Denmark
- Prior art keywords
- gatifloxacin
- aqueous liquid
- liquid preparations
- salt
- sodium edetate
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 abstract 5
- 229960003923 gatifloxacin Drugs 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940037001 sodium edetate Drugs 0.000 abstract 2
- 231100000478 corneal permeability Toxicity 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23543298 | 1998-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1025846T3 true DK1025846T3 (da) | 2006-11-06 |
Family
ID=16986030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99938550T DK1025846T3 (da) | 1998-08-21 | 1999-08-20 | Vandige flydende præparater |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6333045B1 (de) |
| EP (1) | EP1025846B1 (de) |
| JP (1) | JP5138128B2 (de) |
| KR (1) | KR100595956B1 (de) |
| CN (1) | CN1133432C (de) |
| AT (1) | ATE332692T1 (de) |
| AU (1) | AU761040B2 (de) |
| BR (1) | BRPI9906735B8 (de) |
| CA (1) | CA2307632C (de) |
| DE (1) | DE69932313T2 (de) |
| DK (1) | DK1025846T3 (de) |
| ES (1) | ES2264266T3 (de) |
| HK (1) | HK1029934A1 (de) |
| NZ (1) | NZ504017A (de) |
| PT (1) | PT1025846E (de) |
| TW (1) | TW537895B (de) |
| WO (1) | WO2000010570A1 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
| US6740664B2 (en) | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| CA2387016C (en) | 1999-10-08 | 2010-09-28 | William H. Miller | Acrylamide derivatives as fab i inhibitors |
| CA2399516A1 (en) * | 2000-02-01 | 2001-08-09 | Kyorin Pharmaceutical Co., Ltd. | Sulfate of quinolonecarboxylic acid derivatives and the use thereof |
| WO2003088897A2 (en) | 2001-04-06 | 2003-10-30 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
| US20020198209A1 (en) * | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Compositions having enhanced pharmacokinetic characteristics |
| EP1390073A2 (de) * | 2001-05-03 | 2004-02-25 | Allergan, Inc. | Zusammensetzungen mit verbesserten pharmakokinetischen eigenschaften |
| EP1575951B1 (de) | 2002-12-06 | 2014-06-25 | Debiopharm International SA | Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel |
| WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
| US20050085446A1 (en) * | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
| US20040202687A1 (en) * | 2003-04-14 | 2004-10-14 | Babu M.K. Manoj | Ciprofloxacin formulations and methods of making and using the same |
| JP2005008625A (ja) * | 2003-05-23 | 2005-01-13 | Santen Pharmaceut Co Ltd | キノロン系抗菌化合物を含有する点眼液 |
| PL1828167T3 (pl) | 2004-06-04 | 2015-02-27 | Debiopharm Int Sa | Pochodne akryloamidu jako środki antybiotykowe |
| US8476319B2 (en) | 2005-03-10 | 2013-07-02 | 3M Innovative Properties Company | Methods of treating ear infections |
| US8546423B2 (en) | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| EP2054422B1 (de) | 2006-07-20 | 2017-06-14 | Debiopharm International SA | Acrylamidderivate als fab-i-inhibitoren |
| US20100041623A1 (en) * | 2006-10-12 | 2010-02-18 | Shirou Sawa | Aqueous liquid preparation comprising gatifloxacin |
| CN101547695B (zh) * | 2006-10-12 | 2011-04-27 | 杏林制药株式会社 | 具有改进的加替沙星眼内渗透性的含水液体制剂 |
| EP3255045A1 (de) | 2007-02-16 | 2017-12-13 | Debiopharm International SA | Salze, prodrugs und polymorphe von fab i-inhibitoren |
| CA2621616A1 (en) * | 2007-02-19 | 2008-08-19 | Alcon Research, Ltd. | Topical gatifloxacin formulations |
| JP2008247828A (ja) * | 2007-03-30 | 2008-10-16 | Wakamoto Pharmaceut Co Ltd | ラタノプロストを含有する水性医薬組成物。 |
| JP5258331B2 (ja) * | 2008-03-03 | 2013-08-07 | ロート製薬株式会社 | 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物 |
| MX2010010686A (es) * | 2008-03-31 | 2011-02-23 | Kyorin Seiyaku Kk | Preparacion liquida acuosa que contiene gatifloxacina, su produccion y metodo para suprimir la formacion de precipitado durante el almacenamiento a temperatura mas baja y en el momento del congelamiento y descongelamiento de la preparacion liquida ac |
| BRPI0909366A2 (pt) * | 2008-03-31 | 2017-06-13 | Kyorin Seiyaku Kk | preparação líquida aquosa contendo gatifloxacina |
| HUE050147T2 (hu) | 2008-10-07 | 2020-11-30 | Horizon Orphan Llc | Tüdõgyulladás csökkentése levofloxacin belélegzése útján |
| MX345158B (es) | 2008-10-07 | 2017-01-18 | Raptor Pharmaceuticals Inc | Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada. |
| WO2010096242A1 (en) * | 2009-02-18 | 2010-08-26 | Aradigm Corporation | Ph-modulated formulations for pulmonary delivery |
| UA92423C2 (ru) * | 2009-07-24 | 2010-10-25 | Анатолій Альбертович Кузьмін | Антибактериальная композиция |
| AU2010289326B2 (en) | 2009-09-04 | 2015-09-24 | Horizon Therapeutics U.S. Holding Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
| EP2832359B1 (de) | 2012-03-26 | 2018-11-14 | Santen Pharmaceutical Co., Ltd. | Diquafosolhaltige augentropfen |
| JP6085026B2 (ja) | 2012-06-19 | 2017-02-22 | デビオファーム インターナショナル エスエーＤｅｂｉｏｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓａ | （ｅ）−ｎ−メチル−ｎ−（（３−メチルベンゾフラン−２−イル）メチル）−３−（７−オキソ−５，６，７，８−テトラヒドロ−１，８−ナフチリジン−３−イル）アクリルアミドのプロドラッグ誘導体 |
| US10751351B2 (en) | 2016-02-26 | 2020-08-25 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
| JP6886322B2 (ja) * | 2016-03-25 | 2021-06-16 | 興和株式会社 | 眼科用組成物 |
| WO2018031973A1 (en) | 2016-08-12 | 2018-02-15 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
| US11484538B2 (en) | 2020-08-26 | 2022-11-01 | Somerset Therapeutics, Llc | Bromfenac, prednisolone, and moxifloxacin compositions and methods |
| US11298315B2 (en) | 2020-08-26 | 2022-04-12 | Somerset Therapeutics, Llc. | Triamcinolone and moxifloxacin compositions |
| US11382910B2 (en) | 2020-08-26 | 2022-07-12 | Somerset Therapeutics, Llc. | Loteprednol and moxifloxacin compositions and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU553415B2 (en) * | 1983-09-19 | 1986-07-17 | Abbott Japan Co., Ltd. | 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids |
| JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| JPH0696533B2 (ja) | 1987-01-14 | 1994-11-30 | 北陸製薬株式会社 | キノロンカルボン酸の水性組成物 |
| JP2549285B2 (ja) * | 1987-02-02 | 1996-10-30 | 第一製薬株式会社 | 鼻用噴霧剤 |
| JPH01258620A (ja) * | 1988-04-08 | 1989-10-16 | Dai Ichi Seiyaku Co Ltd | 耳疾患用局所製剤 |
| JP3996659B2 (ja) * | 1995-10-25 | 2007-10-24 | 千寿製薬株式会社 | 血管新生抑制剤 |
| JPH09124484A (ja) * | 1995-10-27 | 1997-05-13 | Schering Purau Kk | 点眼剤 |
| WO1998030221A1 (fr) * | 1997-01-10 | 1998-07-16 | Wakamoto Pharmaceutical Co., Ltd. | Composition de type emulsion huile/eau a usage ophtalmique et contenant du difluprednate |
-
1999
- 1999-08-20 ES ES99938550T patent/ES2264266T3/es not_active Expired - Lifetime
- 1999-08-20 AT AT99938550T patent/ATE332692T1/de active
- 1999-08-20 BR BRPI9906735A patent/BRPI9906735B8/pt not_active IP Right Cessation
- 1999-08-20 PT PT99938550T patent/PT1025846E/pt unknown
- 1999-08-20 EP EP99938550A patent/EP1025846B1/de not_active Expired - Lifetime
- 1999-08-20 JP JP2000565891A patent/JP5138128B2/ja not_active Expired - Lifetime
- 1999-08-20 CN CNB998014087A patent/CN1133432C/zh not_active Expired - Lifetime
- 1999-08-20 DE DE69932313T patent/DE69932313T2/de not_active Expired - Lifetime
- 1999-08-20 DK DK99938550T patent/DK1025846T3/da active
- 1999-08-20 AU AU53026/99A patent/AU761040B2/en not_active Expired
- 1999-08-20 NZ NZ504017A patent/NZ504017A/xx not_active IP Right Cessation
- 1999-08-20 KR KR1020007004221A patent/KR100595956B1/ko not_active IP Right Cessation
- 1999-08-20 US US09/529,882 patent/US6333045B1/en not_active Expired - Lifetime
- 1999-08-20 TW TW088114247A patent/TW537895B/zh not_active IP Right Cessation
- 1999-08-20 CA CA002307632A patent/CA2307632C/en not_active Expired - Lifetime
- 1999-08-20 WO PCT/JP1999/004483 patent/WO2000010570A1/ja active IP Right Grant
-
2001
- 2001-02-06 HK HK01100837A patent/HK1029934A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU761040B2 (en) | 2003-05-29 |
| US6333045B1 (en) | 2001-12-25 |
| WO2000010570A1 (fr) | 2000-03-02 |
| CN1133432C (zh) | 2004-01-07 |
| KR20010031240A (ko) | 2001-04-16 |
| JP5138128B2 (ja) | 2013-02-06 |
| BRPI9906735B8 (pt) | 2021-05-25 |
| CA2307632C (en) | 2007-05-22 |
| DE69932313D1 (de) | 2006-08-24 |
| ES2264266T3 (es) | 2006-12-16 |
| BR9906735A (pt) | 2000-08-15 |
| NZ504017A (en) | 2001-09-28 |
| BRPI9906735B1 (pt) | 2015-09-01 |
| HK1029934A1 (en) | 2001-04-20 |
| EP1025846B1 (de) | 2006-07-12 |
| AU5302699A (en) | 2000-03-14 |
| TW537895B (en) | 2003-06-21 |
| CN1275081A (zh) | 2000-11-29 |
| KR100595956B1 (ko) | 2006-07-03 |
| DE69932313T2 (de) | 2007-07-19 |
| EP1025846A4 (de) | 2004-12-29 |
| EP1025846A1 (de) | 2000-08-09 |
| PT1025846E (pt) | 2006-10-31 |
| ATE332692T1 (de) | 2006-08-15 |
| CA2307632A1 (en) | 2000-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE332692T1 (de) | Wässerige flüssige zubereitungen | |
| PE20010400A1 (es) | Formulacion de sal comun y moxifloxacina | |
| IL107533A0 (en) | N'-substituted-n, n'-diacylhydrazines their preparation and their use as insecticides | |
| CA2367505A1 (en) | Coloring ceramics by way of ionic or complex-containing solutions | |
| NO308848B1 (no) | Kromanforbindelse og farmasøytisk preparat som inneholder den | |
| NO941937D0 (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
| BR0109650A (pt) | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca | |
| FI95773B (fi) | Menetelmä vesipitoisen, N-(3,4-dimetoksikinnamoyyli)antraniilihappoa sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
| DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
| DK551885A (da) | Middel og fremgangsmaade til efterbehandling af vasket vasketoej | |
| DE69414194T2 (de) | Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren | |
| AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| DE60136064D1 (de) | Wässrige flüssige preparation von pranoprofen | |
| HUP9904030A2 (hu) | Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására | |
| DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
| BR0206262B1 (pt) | composiÇço antimicrobiana lÍquida, uso da mesma, e, mÉtodo de exterminar ou eliminar vÍrus ou esporos. | |
| DE69815347D1 (de) | Tetrahydrofuranderivate | |
| NO964905D0 (no) | Substituerte benzendikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| DK174885A (da) | Derivater af n-(3-phenylmethylthio-1-oxopropyl)-aminoeddikesyre i form af enantiomere eller blandinger, fremgangsmaade til fremstilling af forbindelserne og laegemiddel indeholdende disse | |
| DK1318821T3 (da) | Væske til hæmofiltrering | |
| KR900014372A (ko) | 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제 | |
| BR0111049A (pt) | Processo para a preparação de ácido 4-(4-piridinil)-benzóico, ou de um seu sal | |
| BR9915333A (pt) | Derivados de 3,4-dihidroquinolina fluorada como inibidores de nos |